WHO ICTRP trial
Clinical study based on intestinal flora on the treatment of Xiexin Decoction on…
ITMCTR2000003944 · International Traditional Medicine Clinical Trial Registry (ITMCTR) · Not Recruiting
Key facts
| Trial ID | ITMCTR2000003944 |
|---|---|
| Public title | Clinical study based on intestinal flora on the treatment of Xiexin Decoction on Metabolic syndrome caused by Olanzapine |
| Scientific title | Clinical study based on intestinal flora on the treatment of Xiexin Decoction on Metabolic syndrome caused by Olanzapine |
| Primary sponsor | Shanghai Mental Health Center |
| Registry | International Traditional Medicine Clinical Trial Registry (ITMCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional study |
| Phase | 0 |
| Countries | China |
| Conditions | Metabolic syndrome of Schizophrenia patients |
| Interventions | experimental group:Xiexin Decoction;control group:metformin;;TrCon |
| Registration date | Aug 24, 2020 |
| Target size | experimental group:60;control group:60 |
| Secondary IDs | ChiCTR2000036717;ChiMCTR2000003944 |
| Registry page | itmctr.ccebtcm.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: